对高通量测序进行评估,以取代用于生物制剂的传统偶然病毒检测试验

Pei-Ju Chin1, Jen-Hui Tsou1,2, Alison Armstrong3

  • 1Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

NPJ vaccines
|December 23, 2025
PubMed
概括

高通量测序 (HTS) 检测出常规测试遗漏的病毒. 对于取代体内测试和可能补充或取代体外测试用于病毒检测,HTS显示出有前途的潜力.